Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide (Zepbound) led to about 20% average body weight loss Semaglutide (Wegovy) led to about 14% average body weight loss
therefore, qualitative copper staining on random liver biopsy samples provides low diagnostic yield
#PharmaIndustry #IndianPharma #HealthcareIndia #PharmaMarketing #MedicalSales #PharmaBrands #IndiaHealthcare #LifeSciences #LinkedInPost To view or add a comment, sign in Big Update for Healthcare in India Semaglutide Patent Expiry (March-2026) One of the most significant upcoming patent expiries is Semaglutide, a blockbuster drug widely used for Type-2 Diabetes and Obesity (brands such as Ozempic and Wegovy)
In the face of accelerated consumption, increasing environmental degradation and the multi-faceted impacts of climate change, we clearly need new ways of manage competing demands on our freshwater resources. Humans use about 4,600 cubic km of water every year, of which 70% goes to agriculture, 20% to industry and 10% to households, says the report, which was launched at the start of the triennial World Water Forum
Always consult a qualified, licensed healthcare professional before starting any new medication, weight-loss program, or prescription treatment
You deserve answers, not just statistics.
